Motivational Interviewing and Medication Review in Coronary Heart Disease

Motivational Interviewing and Medication Review in the Secondary Prevention of Coronary Heart Disease

Low medication adherence in patients with coronary heart disease increases mortality.

This study investigates if an intervention of medication review and counselling can improve patients' medication adherence and treatment results.

The study will investigate the effects of medication review and Motivational Interviewing (MI) on patients with Coronary Heart Disease (CHD). Clinical pharmacists competent in MI and cardiology will conduct medication interviews and medication reviews at the outpatient clinic. The intervention will continue during 9 months, with interviews and reviews as needed.

Follow-up of results will take place 16 months after inclusion (corresponding to 4 months after the end of intervention).

The MI-Component will be quality assured by MITI 4.2-coding (Motivational Interviewing Treatment Integrity). The study will investigate effects on clinical outcomes, medication adherence, patients´ beliefs about medicines and quality of life.

Inclusion Criteria:

• Admitted for angiography
• Verified Coronary Artery Disease (ICD-10 I20-I21)
• Planned for follow up at the out-patient clinic (standard treatment)
• Swedish speaking

Exclusion Criteria:

• Cognitive impairment or any othe condition making interview or phone calls impossible.
• Non-participation in the standard follow-up
• Prior participation in this study